PHYSIOLOGY OF MALONYL COA IN MUSCLE DURING EXERCISE

运动期间肌肉中丙二酰辅酶A的生理学

基本信息

  • 批准号:
    3161880
  • 负责人:
  • 金额:
    $ 11.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-05-01 至 1997-04-30
  • 项目状态:
    已结题

项目摘要

In the liver, malonyl-CoA is the first committed intermediate in the pathway for fatty acid synthesis from glucose and other carbohydrate precursors. This compound inhibits carnitine palmitoyl transferase I (the rate limiting enzyme for fatty acid oxidation) in isolated mitochondria from both liver and skeletal muscle. In times of glucose abundance, activation of acetyl-CoA carboxylase (ACC) causes increased malonyl-CoA concentration in the liver. The high concentration of malonyl-CoA inhibits CPT I so that fatty acid oxidation is inhibited at times when glucose is being utilized for fatty acid synthesis. During times of fasting, elevated plasma glucagon inhibits (via cAMP-triggered phosphorylation) ACC resulting in a decline in malonyl-CoA in skeletal muscle (a non-lipogenic tissue). Skeletal muscle malonyl-CoA decreases markedly in response to fasting and exercise. The principal purpose of the proposed experiments is to elucidate the mechanisms of regulation of malonyl-CoA synthesis in muscle by ACC. The skeletal muscle ACC will be isolated and characterized in terms of molecular weight and kinetic properties. The roles of epinephrine, insulin, and muscle contraction in regulation of ACC will be studied using the hindlimb perfusion system. The role of phosphorylation will be studied using cAMP-dependent protein kinase, AMP-dependent protein kinase, and calcium-calmodulin dependent protein kinase II. The effect of acute exercise bouts and of endurance training on ACC will be studied in rat skeletal muscle. These studies will provide new information on regulation of muscle malonyl-CoA, a putative regulator of fat oxidation in muscle. This information will be important for better understanding the metabolic derangements of diabetes mellitus and for understanding regulation of fat utilization during exercise.
在肝脏中,丙二酰辅酶a是肝脏中第一个参与的中间体

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM WINDER其他文献

WILLIAM WINDER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM WINDER', 18)}}的其他基金

Regulation of Skeletal Muscle LKB1
骨骼肌 LKB1 的调节
  • 批准号:
    7257233
  • 财政年份:
    2006
  • 资助金额:
    $ 11.31万
  • 项目类别:
Regulation of Skeletal Muscle LKB1
骨骼肌 LKB1 的调节
  • 批准号:
    7142762
  • 财政年份:
    2006
  • 资助金额:
    $ 11.31万
  • 项目类别:
Regulation of Skeletal Muscle LKB1
骨骼肌 LKB1 的调节
  • 批准号:
    7858297
  • 财政年份:
    2006
  • 资助金额:
    $ 11.31万
  • 项目类别:
Regulation of Skeletal Muscle LKB1
骨骼肌 LKB1 的调节
  • 批准号:
    7434563
  • 财政年份:
    2006
  • 资助金额:
    $ 11.31万
  • 项目类别:
Regulation of Skeletal Muscle LKB1
骨骼肌 LKB1 的调节
  • 批准号:
    7625147
  • 财政年份:
    2006
  • 资助金额:
    $ 11.31万
  • 项目类别:
PHYSIOLOGY OF MALONYL COA IN MUSCLE DURING EXERCISE
运动期间肌肉中丙二酰辅酶A的生理学
  • 批准号:
    2080690
  • 财政年份:
    1992
  • 资助金额:
    $ 11.31万
  • 项目类别:
PHYSIOLOGY OF MALONYL COA IN MUSCLE DURING EXERCISE
运动期间肌肉中丙二酰辅酶A的生理学
  • 批准号:
    6171270
  • 财政年份:
    1992
  • 资助金额:
    $ 11.31万
  • 项目类别:
PHYSIOLOGY OF MALONYL COA IN MUSCLE DURING EXERCISE
运动期间肌肉中丙二酰辅酶A的生理学
  • 批准号:
    2080688
  • 财政年份:
    1992
  • 资助金额:
    $ 11.31万
  • 项目类别:
PHYSIOLOGY OF MALONYL COA IN MUSCLE DURING EXERCISE
运动期间肌肉中丙二酰辅酶A的生理学
  • 批准号:
    3161881
  • 财政年份:
    1992
  • 资助金额:
    $ 11.31万
  • 项目类别:
Physiology of Malonyl-CoA in Muscle during Exercise
运动过程中肌肉中丙二酰辅酶A的生理学
  • 批准号:
    6535956
  • 财政年份:
    1992
  • 资助金额:
    $ 11.31万
  • 项目类别:

相似海外基金

Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8358448
  • 财政年份:
    2012
  • 资助金额:
    $ 11.31万
  • 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8517552
  • 财政年份:
    2012
  • 资助金额:
    $ 11.31万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7952159
  • 财政年份:
    2009
  • 资助金额:
    $ 11.31万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7952152
  • 财政年份:
    2009
  • 资助金额:
    $ 11.31万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7719194
  • 财政年份:
    2008
  • 资助金额:
    $ 11.31万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7605416
  • 财政年份:
    2007
  • 资助金额:
    $ 11.31万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7605425
  • 财政年份:
    2007
  • 资助金额:
    $ 11.31万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7378753
  • 财政年份:
    2006
  • 资助金额:
    $ 11.31万
  • 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
  • 批准号:
    6825160
  • 财政年份:
    2004
  • 资助金额:
    $ 11.31万
  • 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
  • 批准号:
    2702283
  • 财政年份:
    1997
  • 资助金额:
    $ 11.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了